{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:59:41Z","timestamp":1786982381882,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12325-021-01741-7","type":"journal-article","created":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T23:47:25Z","timestamp":1621554445000},"page":"3389-3398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Effects of Combined Lipid-Lowering Therapy on Low-Density Lipoprotein Cholesterol Variability and Cardiovascular Adverse Events in Patients with Acute Coronary Syndrome"],"prefix":"10.1007","volume":"38","author":[{"given":"Huilian","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"issue":"5","key":"1741_CR1","first-page":"355","volume":"45","author":"JB Ge","year":"2017","unstructured":"Ge JB, Dai YX. Status of diagnosis and treatment of non-ST-segment elevation acute coronary syndrome in China. Zhonghua Xin Xue Guan Bing Za Zhi. 2017;45(5):355\u20138.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"1741_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2147\/VHRM.S209003","volume":"15","author":"I Haraldsson","year":"2019","unstructured":"Haraldsson I, Gan LM, Svedlund S, Torngren K, Westergren HU, Redfors B, et al. PROspective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial: cross-sectional evaluation of coronary flow reserve. Vasc Health Risk Manag. 2019;15:375\u201384.","journal-title":"Vasc Health Risk Manag"},{"key":"1741_CR3","doi-asserted-by":"crossref","first-page":"e13181","DOI":"10.1111\/eci.13181","volume":"50","author":"M Nardin","year":"2019","unstructured":"Nardin M, Verdoia M. Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease. Eur J Clin Investig. 2019;50:e13181.","journal-title":"Eur J Clin Investig"},{"issue":"2","key":"1741_CR4","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.atherosclerosis.2013.12.003","volume":"233","author":"SP Zhao","year":"2014","unstructured":"Zhao SP, Yu BL, Peng DQ, Huo Y. The effect of moderate-dose versus double-dose statins on patients with acute coronary syndrome in China: Results of the CHILLAS trial. Atherosclerosis. 2014;233(2):707\u201312.","journal-title":"Atherosclerosis"},{"key":"1741_CR5","first-page":"7092414","volume":"2018","author":"X Liang","year":"2018","unstructured":"Liang X, He Q, Zhao Q. Effect of Stains on LDL Reduction and Liver Safety: A Systematic Review and Meta-Analysis. BioMed Res Int. 2018;2018:7092414.","journal-title":"BioMed Res Int"},{"issue":"11","key":"1741_CR6","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1091\/mbc.e16-03-0154","volume":"27","author":"TA Johnson","year":"2016","unstructured":"Johnson TA, Pfeffer SR. Ezetimibe-sensitive cholesterol uptake by NPC1L1 protein does not require endocytosis. Mol Biol Cell. 2016;27(11):1845\u201352.","journal-title":"Mol Biol Cell"},{"key":"1741_CR7","doi-asserted-by":"publisher","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ. 2014 AHA\/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014 Dec 23;64(24):e139\u2013e228. https:\/\/doi.org\/10.1016\/j.jacc.2014.09.017. Epub 2014 Sep 23. Erratum in: J Am Coll Cardiol. 2014 Dec 23;64(24):2713-4. Dosage error in article text. PMID: 25260718.","DOI":"10.1016\/j.jacc.2014.09.017"},{"issue":"2","key":"1741_CR8","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0002-9149(99)00653-0","volume":"85","author":"J Zhu","year":"2000","unstructured":"Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol. 2000;85(2):140\u20136.","journal-title":"Am J Cardiol"},{"issue":"12","key":"1741_CR9","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1161\/01.CIR.101.12.1372","volume":"101","author":"B Schieffer","year":"2000","unstructured":"Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, et al. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation. 2000;101(12):1372\u20138.","journal-title":"Circulation"},{"issue":"9753","key":"1741_CR10","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670\u201381.","journal-title":"Lancet"},{"issue":"10","key":"1741_CR11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1046\/j.1464-5491.2001.00542.x","volume":"18","author":"PR Maxwell","year":"2001","unstructured":"Maxwell PR, Timms PM, Chandran S, Gordon D. Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes. Diabet Med. 2001;18(10):777\u201380.","journal-title":"Diabet Med"},{"issue":"10","key":"1741_CR12","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1185\/03007990802365094","volume":"24","author":"H Bays","year":"2008","unstructured":"Bays H, Sapre A, Taggart W, Liu J, Capece R, Tershakovec A. Long-term (48-week) safety of ezetimibe 10 mg\/day coadministered with simvastatin compared to simvastatin alone in patients with primary hypercholesterolemia. Curr Med Res Opin. 2008;24(10):2953\u201366.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"1741_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.clinthera.2005.02.011","volume":"27","author":"L Masana","year":"2005","unstructured":"Masana L, Mata P, Gagne C, Sirah W, Cho M, Johnson-Levonas AO, et al. Long-term safety and tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study. Clin Ther. 2005;27(2):174\u201384.","journal-title":"Clin Ther"},{"issue":"29","key":"1741_CR14","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1093\/eurheartj\/ehx162","volume":"38","author":"N Hagiwara","year":"2017","unstructured":"Hagiwara N, Kawada-Watanabe E, Koyanagi R, Arashi H, Yamaguchi J, Nakao K, et al. Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial. Eur Heart J. 2017;38(29):2264\u201376.","journal-title":"Eur Heart J"},{"issue":"6","key":"1741_CR15","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/ccd.23171","volume":"79","author":"P Liu","year":"2012","unstructured":"Liu P, Jiang J, Li J, Hong T, Zhang Y, Yu R, et al. Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention (ISCAP study): rationale and design. Catheter Cardiovasc Interv. 2012;79(6):967\u201371.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"1741_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.atherosclerosis.2009.12.001","volume":"210","author":"T Dohi","year":"2010","unstructured":"Dohi T, Miyauchi K, Okazaki S, Yokoyama T, Yanagisawa N, Tamura H, et al. Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): a follow-up study. Atherosclerosis. 2010;210(2):497\u2013502.","journal-title":"Atherosclerosis"},{"key":"1741_CR17","first-page":"169","volume":"20","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Hu H, Yang J, Yao Q, Xu H, Yu Y, et al. The efficacy and safety of statin in combination with ezetimibe compared with double-dose statin in patients with high cardiovascular risk: a meta-analysis. Bosn J Basic Med Sci. 2019;20:169.","journal-title":"Bosn J Basic Med Sci."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01741-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-021-01741-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01741-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T20:12:25Z","timestamp":1699042345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-021-01741-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1741"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01741-7","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}